Ocular adverse effects associated with cyclooxygenase-2 inhibitors

Archives of Ophthalmology

Volumn 124, Issue 2, 2006, Pages 277-279

  Fraunfelder, Frederick W ^a   Solomon, Jonathan ^b   Mehelas, Thomas J ^b  

^a CASEY EYE INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AINEX; CELECOXIB; CODEINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DIAZEPAM; ETODOLAC; ISOTRETINOIN; LEVOTHYROXINE; LUMIRACOXIB; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SULFONAMIDE; VALDECOXIB;

ARTICLE; BLINDNESS; BLURRED VISION; CONJUNCTIVITIS; DRUG SELECTIVITY; DYSMENORRHEA; ENZYME INHIBITION; EYE TOXICITY; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HUMAN; MYOPIA; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; PROVOCATION TEST; RHEUMATOID ARTHRITIS; STROKE; TRANSITIONAL BLINDNESS; VISUAL DISORDER; VISUAL FIELD DEFECT; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CONJUNCTIVITIS; CYCLOOXYGENASE 2 INHIBITORS; ETODOLAC; HUMANS; ISOXAZOLES; LACTONES; MIDDLE AGED; PYRAZOLES; SULFONAMIDES; SULFONES; VISION DISORDERS;

EID: 32644465408     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.124.2.277     Document Type: Article

References (16)

1. Hardman JG, Limbird L, Gilman AG. The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001.
2. Coulter DM, Clark DWJ, Savage RL. Celecoxib, rofecoxib, and acute temporary visual impairment. BMJ. 2003;327:1214-1215.
3. Lund BC, Neiman RF. Visual disturbance associated with celecoxib. Pharmacotherapy. 2001;21:114-115.
4. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf. 1994;10:93-102.
5. Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54:315-321.
6. Haefliger IO, Meyer P, Flammer J, Luscher TF. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol. 1994;39:123-132.
7. Tullio CJ. Ibuprofen-induced visual disturbance. Am J Hosp Pharm. 1981;38:1362.
8. Nicastro NJ. Visual disturbances associated with over-the-counter ibuprofen in three patients. Ann Ophthalmol. 1989;21:447-450.
9. Bovino JA, Marcus FF. The mechanism of transient myopia induced by sulfonamide therapy. Am J Ophthalmol. 1982;94:99-101.
10. Chirls IA, Norris JW. Transient myopia associated with vaginal sulfanilamide suppositories. Am J Ophthalmol. 1984;98:120-121.
11. Hook SR, Holladay JT, Prager TC, Goosey JD. Transient myopia induced by sulfonamides. Am J Ophthalmol. 1986;101:495-496.
12. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004;111:109-111.
13. Fraunfelder FT, Fraunfelder FW. Drug-Induced Ocular Side Effects. 5th ed. Woburn, Mass: Butterworth-Heinemann; 2001.
14. Lutz EG. Allergic conjunctivitis due to diazepam. Am J Psychiatry. 1975;132:548.
15. Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001;132:299-305.
16. Fraunfelder FT, LaBraico JM, Meyer SM. Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol. 1985;100:534-537.